NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
IntroductionImproving treatments for Diffuse Large B-Cell Lymphoma (DLBCL) is challenged by the vast heterogeneity of the disease. Nuclear factor-κB (NF-κB) is frequently aberrantly activated in DLBCL. Transcriptionally active NF-κB is a dimer containing either RelA, RelB or cRel, but the variabilit...
Päätekijät: | , , , , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2023-06-01
|
Sarja: | Frontiers in Oncology |
Aiheet: | |
Linkit: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1181660/full |